🇺🇸 FDA
Patent

US 8618090

Inhibitors of the plasmodial surface anion channel as antimalarials

granted A61KA61K31/165A61K31/4155

Quick answer

US patent 8618090 (Inhibitors of the plasmodial surface anion channel as antimalarials) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/165, A61K31/4155, A61K31/421, A61K31/423